Chimerix, Inc. (CMRX)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about Chimerix, Inc. (CMRX)
Go deeper and ask any question about CMRX
Company Performance
Current Price
as of Sep 13, 2024$0.85
P/E Ratio
N/A
Market Cap
$76.64M
Description
Chimerix, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes Brincidofovir for the treatment of adenovirus, cytomegalovirus, and smallpox. The company was founded in April 2000 and is headquartered in Durham, NC.
Metrics
Overview
- HQDurham, NC
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerCMRX
- Price$0.855-1.72%
Trading Information
- Market Cap$76.64M
- Float89.17%
- Average Daily Volume (1m)890,422
- Average Daily Volume (3m)490,496
- EPS-$0.95
Company
- Revenue$0.14M
- Rev Growth (1yr)396.15%
- Net Income-$20.69M
- Gross Margin81.40%
- EBITDA Margin-17,680.62%
- EBITDA-$22.81M
- EV-$68.15M
- EV/Revenue-473.23
- P/EN/A
- P/S532.18
Documents
SEC Filings
Factset Street Account